PLSE · Pulse Biosciences, Inc.
$36.97
+1.84 (+5.24%)
At close · Aug 3
Market Cap
$2.43B
Shares
69.21M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-02-12 | KEVIN DANAHY | Officer | 50,000 | 2026-02-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-09 | KEVIN DANAHY | Officer | 75,000 | 2026-02-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-18 | KEVIN DANAHY | Officer | 25,000 | 2025-09-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-11 | DARRIN UECKER | Director, Officer | 120,000 | 2025-09-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-06-13 | DARRIN UECKER | Officer, Director | 15,000 | 2025-06-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-06-12 | DARRIN UECKER | Officer, Director | 15,000 | 2025-06-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–6 of 6 filings
Key facts
CIK
1625101
CUSIP
74587B101
13F (30d)
15 filings
15 filers
Visit website
Investor relations